Regencell Bioscience Holdings Limited
RGCNASDAQHealthcareDrug Manufacturers - Specialty & Generic
Previous close
$5.30
−$0.14 · -2.57%
RGC company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
26
Expensive
Momentum
31
Weakening
Sentiment
43
Mixed
Risk resilience
24
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteRegencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Headquarters
- HK
- CEO
- Yat-Gai Au
- Listed since
- Jul 16, 2021
- Employees
- 10
Market position
Day range
Current $5.30
52-week range
Current $5.30
- Open
- $5.44
- Previous close
- $5.44
- Volume
- 153.53K
- 0.63× average
- Average volume
- 242.84K
- Average daily volume
- Market cap
- 2.63B USD
- Beta
- 1.49
- Market reference 1
- 50-day average
- $7.3195
- -27.59% below average
- 200-day average
- $20.2906
- -73.88% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 8.42B USD
- P/E (TTM)
- -373.24×
- P/B (TTM)
- 2,149.28×
- P/S (TTM)
- 0×
- EV / EBITDA
- -2,639.6×
- Earnings yield
- -0.04%
- Free cash flow yield
- -0.04%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 0.00%
- Operating margin
- 0.00%
- Net margin
- 0.00%
- Return on equity
- -73.75%
- Return on assets
- -62.27%
- Return on invested capital
- -69.75%
Financial health
- Debt / equity
- 0.32×
- Current ratio
- 7.39×
Earnings
- Latest EPS result
- -0.01
EPS: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Rating distribution
4 ratingsLimited analyst sample: 4 ratings. Interpret the distribution with caution.
RGC news
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
$0.88
2017 complete year+4.8% since 2013
$0.84
2,013
$0.88
2,014
$0.88
2,015
$0.88
2,016
$0.88
2,017
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Feb 15, 2018 | $8.36Quarterly | — | Feb 26, 2018 |
Dividend | Dec 1, 2017 | $8.36Quarterly | — | Dec 15, 2017 |
Dividend | Aug 31, 2017 | $8.36Quarterly | — | Sep 15, 2017 |
Dividend | Jun 1, 2017 | $8.36Quarterly | — | Jun 15, 2017 |
Dividend | Mar 1, 2017 | $8.36Quarterly | — | Mar 15, 2017 |
Dividend | Dec 1, 2016 | $8.36Quarterly | — | Dec 15, 2016 |
Ex-dividend Feb 15, 2018
$8.36
Quarterly
Payment Feb 26, 2018
Ex-dividend Dec 1, 2017
$8.36
Quarterly
Payment Dec 15, 2017
Ex-dividend Aug 31, 2017
$8.36
Quarterly
Payment Sep 15, 2017
Ex-dividend Jun 1, 2017
$8.36
Quarterly
Payment Jun 15, 2017
Ex-dividend Mar 1, 2017
$8.36
Quarterly
Payment Mar 15, 2017
Ex-dividend Dec 1, 2016
$8.36
Quarterly
Payment Dec 15, 2016
RGC peers
ETFs holding RGC
Funds reporting this stock among their holdings, ordered by reported position size.
Fidelity Nasdaq Composite Index ETFONEQ- Market value
- 661.98K
- Weight
- 0.01%
- AUM
- 10.35B USD
- Expense ratio
- 0.21%
- Price / 1D
- $103.14+0.41%
State Street SPDR S&P China ETFGXC- Market value
- 21.82K
- Weight
- 0.00%
- AUM
- 474.65M USD
- Expense ratio
- 0.59%
- Price / 1D
- $91.50+0.51%
Invesco S&P Emerging Markets Momentum ETFEEMO- Market value
- 2.71K
- Weight
- 0.01%
- AUM
- 26.79M USD
- Expense ratio
- 0.29%
- Price / 1D
- $22.13+0.86%
Continue in GoAI
Research RGCresearch.disclaimer